A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

Autor: Holten, J. van., Pavelka, K., Vencovsky, J., Stahl, H., Rozman, B., Genovese, M., Kivitz, A. J., Alvaro, J., Nuki, G., Furst, D. E., Herrero-Beaumont, G., McInnes, I. B., Musikic, P., Tak, P. P.
Zdroj: Annals of the Rheumatic Diseases; Jan2005, p64-69, 6p
Databáze: Complementary Index